Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Jan 10, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-002713.pdf
0001104659-22-002713.rtf
0001104659-22-002713.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000909.pdf
0001104659-22-000909.rtf
0001104659-22-000909.xls
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000917.pdf
0001104659-22-000917.rtf
0001104659-22-000917.xls
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000933.pdf
0001104659-22-000933.rtf
0001104659-22-000933.xls
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000923.pdf
0001104659-22-000923.rtf
0001104659-22-000923.xls
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000925.pdf
0001104659-22-000925.rtf
0001104659-22-000925.xls
Jan 04, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-000929.pdf
0001104659-22-000929.rtf
0001104659-22-000929.xls
Dec 20, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-151439.pdf
0001104659-21-151439.rtf
0001104659-21-151439.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 10, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000093751-21-000723.pdf
0000093751-21-000723.rtf
Dec 09, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-147860.pdf
0001104659-21-147860.rtf
0001104659-21-147860.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2022 Intercept Pharmaceuticals, Inc.